A case report of disseminated verrucosis secondary to ustekinumab in a patient with Crohn’s disease

Ustekinumab is a biologic agent with Food and Drug Administration approval for the treatment of moderate-to-severe plaque psoriasis, psoriatic arthritis, ulcerative colitis, and Crohn’s disease. It functions to inhibit the p40 subunit common to both interleukin-12 and interleukin-23. These pro-infla...

Descripción completa

Detalles Bibliográficos
Autores principales: Svoboda, Steven A, Rush, Patrick S, Sharghi, Kevin G, Rady, Peter L, Tyring, Stephen K, Eikenberg, Joshua D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
JCMS Case report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7975484/
https://www.ncbi.nlm.nih.gov/pubmed/33796316
http://dx.doi.org/10.1177/2050313X211003056

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7975484/
https://www.ncbi.nlm.nih.gov/pubmed/33796316
http://dx.doi.org/10.1177/2050313X211003056

Ejemplares similares